{"Ticker": "ABC", "Company": "AmerisourceBergen", "Sector": "Health Care", "Updated": "2022-10-11", "Rating": [{"Date": "2022-10-11", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$160 to $169"}, {"Date": "2022-08-22", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": ""}, {"Date": "2022-07-11", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$150"}, {"Date": "2022-06-07", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$167 to $178"}, {"Date": "2022-05-26", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Overweight", "Target_Change": ""}, {"Date": "2022-04-12", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$178"}, {"Date": "2022-04-01", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$180"}, {"Date": "2021-02-04", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": ""}, {"Date": "2021-01-06", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Neutral", "Target_Change": ""}, {"Date": "2020-06-15", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$112"}, {"Date": "2020-04-23", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$105"}, {"Date": "2020-04-01", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$93 to $106"}, {"Date": "2020-02-07", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$112"}, {"Date": "2019-09-12", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2019-04-11", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2019-04-10", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": ""}, {"Date": "2019-04-10", "Rating": "Downgrade", "Organization": "BofA/Merrill", "Rating_Change": "Buy to Underperform", "Target_Change": ""}, {"Date": "2019-01-17", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$89"}, {"Date": "2018-07-20", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": ""}, {"Date": "2018-03-08", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$104"}, {"Date": "2018-02-27", "Rating": "Resumed", "Organization": "BofA/Merrill", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2018-02-08", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$117 to $113"}, {"Date": "2018-02-07", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$105 to $112"}, {"Date": "2018-01-30", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$108 to $117"}, {"Date": "2018-01-23", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$88 to $108"}, {"Date": "2018-01-05", "Rating": "Initiated", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": ""}, {"Date": "2017-12-15", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": ""}]}